Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Scientific Reports|May 6, 2016
Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell modelsChien Tai Hong, Kai-Yin Chau, Anthony H V Schapira
Journal of Molecular Neuroscience : MN|May 18, 2013
Pramipexole reduces phosphorylation of α-synuclein at serine-129Kai-Yin Chau, J Mark Cooper, Anthony Henry V Schapira
Scientific Reports|August 27, 2016
The Cytomegalovirus protein pUL37×1 targets mitochondria to mediate neuroprotectionChien Tai Hong, Kai-Yin Chau, Anthony H V Schapira
Journal of Neurochemistry|October 7, 2021
Glucocerebrosidase 1 and leucine-rich repeat kinase 2 in Parkinson disease and interplay between the two genesChiao-Yin Lee, Elisa Menozzi, Kai-Yin Chau, et al.
Journal of Neurochemistry|October 29, 2015
Mitochondrial and lysosomal biogenesis are activated following PINK1/parkin-mediated mitophagyDavor Ivankovic, Kai-Yin Chau, Anthony H V Schapira, et al.
The Journal of Cell Biology|April 20, 2016
PINK1 disables the anti-fission machinery to segregate damaged mitochondria for mitophagyKenneth R Pryde, Heather L Smith, Kai-Yin Chau, et al.
Journal of Neurochemistry|June 5, 2009
Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesisKai-Yin Chau, Hey Long Ching, Anthony H V Schapira, et al.
Cells|July 2, 2021
Neuroprotection in Glaucoma: NAD<sup>+</sup>/NADH Redox State as a Potential Biomarker and Therapeutic TargetBledi Petriti, Pete A Williams, Gerassimos Lascaratos, et al.
Journal of the Neurological Sciences|December 23, 2008
Protection against paraquat and A53T alpha-synuclein toxicity by cabergoline is partially mediated by dopamine receptorsKai-Yin Chau, L V Prasad Korlipara, J Mark Cooper, et al.
Pageof 4